|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.10 EUR | -2.42% |
|
-8.33% | +10.74% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 18.39x | 2.08x | -2.07x | 3.96x | 10.22x | 11.85x | 0.56% | 70.73B | ||
| 26.81x | 4.05x | 1.94x | 5.55x | 16.3x | 20.21x | 0.59% | 54.27B | ||
| 37.72x | 7.76x | 0.7x | 12.9x | 24.55x | 28.72x | -.--% | 49.28B | ||
| -44.25x | 2.48x | 0.34x | 3.17x | 9.36x | 10.92x | 3.41% | 39.94B | ||
| 25.48x | 1.63x | -3.1x | 3.48x | 11.99x | 13.83x | -.--% | 30.36B | ||
| 61.3x | 4.46x | -0.92x | 3.69x | 34.6x | 25.51x | -.--% | 25.96B | ||
| -6.44x | 3.91x | -0.33x | 8.96x | -5.51x | -5.15x | -.--% | 22.14B | ||
| 64.91x | 5.83x | 0.42x | 6.37x | 43.87x | 49.49x | -.--% | 19.96B | ||
| -38.46x | -6.82x | 0.93x | 18.32x | -50.14x | -57.95x | -.--% | 16.77B | ||
| 24.55x | 3.6x | 0.02x | 5.25x | 13.74x | 19.03x | -.--% | 16.72B | ||
| -113.61x | 12404.66x | 2.58x | 12.2x | -87.33x | -121.72x | -.--% | 12.05B | ||
| 18.38x | - | 0.21x | 3.75x | 14.48x | 16.91x | -.--% | 12B | ||
| 54.25x | 22.12x | 0.51x | 32.82x | 46.41x | 47.87x | 0.17% | 10.92B | ||
| 48.77x | - | 5.31x | - | - | - | -.--% | 10.74B | ||
| 13.31x | 1.18x | 0.49x | 1.88x | 7.49x | 10.11x | 2.5% | 6.86B | ||
| 61.19x | 7.91x | 0.84x | 6x | 26.81x | 40.23x | -.--% | 6.1B | ||
| 27.8x | - | 1.36x | 7.45x | 19.78x | 23.62x | 0.37% | 5.68B | ||
| 58.77x | 4.15x | -0.76x | - | - | - | - | 5.58B | ||
| -43.75x | - | -0.79x | - | - | - | - | 5.51B | ||
| Average | 15.53x | 831.27x | 0.40x | 8.48x | 8.54x | 8.34x | 0.45% | 22.19B | |
| Weighted average by Cap. | 16.15x | 389.50x | 0.02x | 7.27x | 11.38x | 12.00x | 0.56% |
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
- Sector Zai Lab Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















